OX40-OX40L Axis in Cutaneous T-Cell Lymphomas: Pathogenic, Prognostic, and Potential Therapeutic Perspectives

Area of Science:

• Immunology
• Dermatology
• Oncology

Background:

• Cutaneous T-cell lymphomas (CTCLs), including mycosis fungoides (MF) and Sézary syndrome (SS), involve CD4+ T-helper cell proliferation.
• Neoplastic cell and tumor microenvironment interactions, mediated by cytokines and cell-surface proteins, drive CTCL pathogenesis.
• OX40 (CD134), a TNF receptor superfamily member, acts as an induced costimulatory molecule crucial for T-cell interactions.

Purpose of the Study:

• To review the literature on the OX40-OX40L interaction in CTCLs.
• To highlight the pathogenic and prognostic significance of OX40-OX40L in CTCL.
• To compare OX40-OX40L roles in CTCLs versus inflammatory skin diseases and discuss therapeutic potential.

Main Methods:

• Narrative literature review.
• Analysis of studies on OX40-OX40L expression and function in CTCL.
• Comparative analysis with atopic dermatitis and psoriasis.

Main Results:

• The OX40-OX40L axis is implicated in CTCL pathogenesis and has prognostic value.
• Expression and function of OX40-OX40L differ between CTCLs and inflammatory skin conditions.
• Targeting the OX40-OX40L pathway is a potential therapeutic strategy for CTCL.

Conclusions:

• The OX40-OX40L interaction is a significant factor in CTCL development and progression.
• Understanding OX40-OX40L in CTCL provides insights into its role in other skin diseases.
• Targeting the OX40-OX40L axis represents a promising avenue for novel CTCL therapies.